Grobs, Y.; Awada, C.; Lemay, S.-E.; Romanet, C.; Bourgeois, A.; Toro, V.; Nadeau, V.; Shimauchi, K.; Orcholski, M.; Breuils-Bonnet, S.;
et al. Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension. Int. J. Mol. Sci. 2021, 22, 2919.
https://doi.org/10.3390/ijms22062919
AMA Style
Grobs Y, Awada C, Lemay S-E, Romanet C, Bourgeois A, Toro V, Nadeau V, Shimauchi K, Orcholski M, Breuils-Bonnet S,
et al. Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension. International Journal of Molecular Sciences. 2021; 22(6):2919.
https://doi.org/10.3390/ijms22062919
Chicago/Turabian Style
Grobs, Yann, Charifa Awada, Sarah-Eve Lemay, Charlotte Romanet, Alice Bourgeois, Victoria Toro, Valérie Nadeau, Kana Shimauchi, Mark Orcholski, Sandra Breuils-Bonnet,
and et al. 2021. "Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension" International Journal of Molecular Sciences 22, no. 6: 2919.
https://doi.org/10.3390/ijms22062919
APA Style
Grobs, Y., Awada, C., Lemay, S.-E., Romanet, C., Bourgeois, A., Toro, V., Nadeau, V., Shimauchi, K., Orcholski, M., Breuils-Bonnet, S., Tremblay, E., Provencher, S., Paulin, R., Boucherat, O., & Bonnet, S.
(2021). Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension. International Journal of Molecular Sciences, 22(6), 2919.
https://doi.org/10.3390/ijms22062919